Status:
ACTIVE_NOT_RECRUITING
A Study of a Novel Scheimpflug Device in Diagnosing Keratoconus
Lead Sponsor:
Tianjin Eye Hospital
Conditions:
Scansys
Pentacam
Eligibility:
All Genders
Brief Summary
Comparison of the screening and diagnosis ability of the novel Scheimpflug-based tomography device (Scansys) with Pentacam and the Scheimpflug-based biomechanics device (Corvis ST) for keratoconus.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Best corrected visual acuity (BCVA) ≥ 20/20;
- No other eye diseases except myopia and astigmatism;
- The cornea was transparent, and there was no cloud or pannus;
- Exclusion Criteria:
- The presence of ocular diseases other than myopia and keratoconus;
- Ocular trauma;
- Previous ocular surgery;
- Patients were required to stop wearing soft contact lenses for at least 2 weeks and rigid contact lenses for at least 4 weeks before examination;
- Pregnant and lactating women;
Exclusion
Key Trial Info
Start Date :
May 4 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06119321
Start Date
May 4 2023
End Date
December 31 2024
Last Update
November 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tiajin Eye Hospital
Tianjin, Tianjin Municipality, China